C07C 323/12
The carbon skeleton being acyclic and saturated
Official title: the carbon skeleton being acyclic and saturated
C07C323/12 (The carbon skeleton being acyclic and saturated) appears on 515 US grants and 408 published applications in this corpus.
Search patents in C07C- Granted patents
- 515
- Published applications
- 408
- Assignees
- 326
- Inventors
- 1,418
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 6 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 6 | 0 |
| 1990 | 10 | 0 |
| 1991 | 12 | 0 |
| 1992 | 14 | 0 |
| 1993 | 13 | 0 |
| 1994 | 12 | 0 |
| 1995 | 13 | 0 |
| 1996 | 22 | 0 |
| 1997 | 28 | 0 |
| 1998 | 16 | 0 |
| 1999 | 15 | 0 |
| 2000 | 14 | 0 |
| 2001 | 16 | 4 |
| 2002 | 18 | 15 |
| 2003 | 12 | 20 |
| 2004 | 11 | 19 |
| 2005 | 9 | 17 |
| 2006 | 11 | 11 |
| 2007 | 16 | 14 |
| 2008 | 12 | 14 |
| 2009 | 6 | 16 |
| 2010 | 6 | 10 |
| 2011 | 13 | 17 |
| 2012 | 9 | 13 |
| 2013 | 14 | 15 |
| 2014 | 13 | 18 |
| 2015 | 14 | 8 |
| 2016 | 11 | 16 |
| 2017 | 10 | 16 |
| 2018 | 8 | 23 |
| 2019 | 13 | 15 |
| 2020 | 15 | 13 |
| 2021 | 16 | 17 |
| 2022 | 14 | 22 |
| 2023 | 15 | 19 |
| 2024 | 10 | 19 |
| 2025 | 14 | 20 |
| 2026 | 9 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cationic lipid having disulfide bond, lipid membrane structure including same, nucleic acid introduction agent and pharmaceutical composition containing any one of same, method for introducing nucleic acid into cell or target cell, and method for producing cellular pharmaceutical29 Sep 2026US 12,746,202 B2National University Corporation Chiba University
- Spleen-targeted ionizable lipid compound, composition comprising same and use thereof1 Sep 2026US 12,723,016 B2Beijing Carrius Bio Ltd.
- Selective hydrogenation of alkynes to alkenes in the presence of a phosphorus compound and an organic sulphur compound30 Jun 2026US 12,668,559 B2Dsm IP Assets B.V.
- Degradable lipid for active molecule delivery and lipid nanoparticle thereof30 Jun 2026US 12,668,572 B2Beijing Carrius Bio Ltd.
- Synthetic lipids for mRNA delivery16 Jun 2026US 12,653,792 B2Trustees of Tufts College
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Polythiol, polymerizable composition for optical materials, optical material, and method for producing same10 Sep 2026US 2026/0265439 A1Hoya Lens Thailand Ltd.
- Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same20 Aug 2026US 2026/0242532 A1I-Sens, Inc.
- Degradable cationic lipid containing a disulfide bond and applications thereof13 Aug 2026US 2026/0234104 A1Xiamen Sinopeg Biotech Co., Ltd.
- Thrombolytic activity of disulfide reducing agents13 Aug 2026US 2026/0234154 A1Georgia Tech Research Corporation
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Low viscosity polythiol and method therefor146US 5,225,472 ACourtaulds Aerospace, Inc. · 1993
- Thermal inkjet printhead and high-efficiency polycrystalline silicon resistor system for use therein141US 6,315,384 B1Hewlett-Packard Company · 2001
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions103US 5,614,548 AWake Forest University · 1997